Yeah, you would think if IPCI version has no issues, FDA would have ok it by now. We have no information why IPCI haven't gotten approval yet. It's not a patent issue since Zydus got their approval.
That's not looking too good someone beat IPCI to the market. Originally we have predicted another approval year end, but it seems to be getting close to missing that window.